Clinical trials

  • CEMIPLIMAB for Cutaneous squamous cell carcinoma
  • NNC0497-0040 for Type 1 diabetes|Overweight|Obesity
  • PEMBROLIZUMAB for Triple negative breast cancer
  • Semaglutide for Non-ST-elevation myocardial infarction (NSTEMI)|Unstable angina|Diabetes mellitus
  • lerodalcibep for Heterozygous familial hypercholesterolemia
  • L-PHENYLALANYL-2-METHYLALANYL-L-ALFA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALFA-ASPARTYL-L-VALYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-LEUCYL-L-ALFA-GLUTAMYL-L-ALFA-GLUTAMYL-L-LYSYL-L-ARGINYL-L-VALYL-L-ARGINYL-L-ALFA-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-ALFA-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-L-LYSYL-L-GLUTAMINYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-PROLYL-L-PROLYLGLYCYL-L-LYSYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL]-L-LYSINE for Obesity | Type 2 diabetes
  • Haemophilus influenzae; Klebsiella ozaenae; Klebsiella pneumoniae; Neisseria catarrhalis; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Streptococcus viridans (bacterial lysates) for Respiratory tract infections
  • Rafutrombopag ethanolamine for Chemotherapy-induced thrombocytopenia|Solid tumor
  • L-PHENYLALANYL-2-METHYLALANYL-L-ALFA-GLUTAMYLGLYCYL-L-THREONYL-L-PHENYLALANYL-L-THREONYL-L-SERYL-L-ALFA-ASPARTYL-L-VALYL-L-SERYL-L-LYSYL-L-GLUTAMINYL-L-LEUCYL-L-ALFA-GLUTAMYL-L-ALFA-GLUTAMYL-L-LYSYL-L-ARGINYL-L-VALYL-L-ARGINYL-L-ALFA-GLUTAMYL-L-PHENYLALANYL-L-ISOLEUCYL-L-ALFA-GLUTAMYL-L-TRYPTOPHYL-L-LEUCYL-L-LYSYL-L-GLUTAMINYLGLYCYLGLYCYL-L-PROLYL-L-SERYL-L-SERYLGLYCYL-L-LYSYL-L-PROLYL-L-PROLYL-L-PROLYLGLYCYL-L-LYSYL-N6-[N-(19-CARBOXY-1-OXONONADECYL)-L-GAMMA-GLUTAMYL]-L-LYSINE for Obesity
  • cagrilintide for Obesity
  • IBI3009 for Extensive-stage small cell lung cancer
  • Clinical trial in Atopic dermatitis